Target intelligence / Profile preview

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 1 (NDUFAF1)

Target
NDUFAF1
Molecular classification
Assembly factor, Mitochondrial protein, Enzyme complex accessory protein, Other
01

Overview

NDUFAF1 is a mitochondrial protein that acts as an essential assembly factor for NADH:ubiquinone oxidoreductase (complex I), the largest enzyme of the mitochondrial electron transport chain[2][1]. It assists in the stepwise integration of various subunits and stabilizes key assembly intermediates, specifically by locking the ND3 subunit in a conformation that prevents misassembly[1][3]. NDUFAF1 forms part of early assembly intermediates with other proteins (such as ACAD9 and ECSIT) and has been shown to interact structurally with both protein and lipid components critical to mitochondrial architecture. Genetic mutations of NDUFAF1 in humans lead to complex I deficiencies manifesting as varied and severe diseases, including lethal neonatal mitochondrial disease, cardiomyopathy, and neurodegeneration. Currently, there are no known direct pharmacological agents targeting NDUFAF1, but its function is central to maintaining mitochondrial respiratory function and cellular energy homeostasis[2][1][3][4].

Other names
Complex I intermediate-associated protein 30, mitochondrialCIA30CGI-65MC1DN11
02

Biological functions

Complex I assemblyStabilization and scaffolding of intermediatesCellular energy metabolismMitochondrial electron transport
03

Disease associations

Mitochondrial diseaseCardiomyopathy (including fatal infantile hypertrophic cardiomyopathy)LeukodystrophyCardioencephalomyopathyMacrocephaly with progressive leukodystrophyLeigh syndromeLeber hereditary optic neuropathyParkinson diseaseMyopathyLiver disease
04

Safety considerations

Broad systemic disease due to mitochondrial dysfunction (muscle, cardiac, neurologic consequences)Lactic acidosis (as in mitochondrial cardiomyopathy)No direct safety data for targeting NDUFAF1 specifically (modulation may risk broader mitochondrial impairment)
05

Biomarkers

Mutations in NDUFAF1 (patient genetic screening for mitochondrial disorders)Enzymatic activity assays of complex I (used in diagnosis)Blood lactate levels (clinical marker in affected individuals)

Beyond the preview

Go deeper on NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 1 (NDUFAF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 1 (NDUFAF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call